Treatment intensity and characteristics of MRSA infection in CF

Journal of Cystic Fibrosis

Volumn 10, Issue 3, 2011, Pages 201-206

  Muhlebach, Marianne S ^a   Miller, Meredith ^a   LaVange, Lisa M ^b   Mayhew, Greg ^b   Goodrich, Jennifer S ^c   Miller, Melissa B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA HOSPITALS   (United States)

Author keywords

Medication use; Methicillin resistant Staphylococcus aureus (MRSA); Molecular typing; Outcome

Indexed keywords

ADOLESCENT; ADULT; AGE; ANTIBIOTIC SENSITIVITY; ARTICLE; CLINICAL FEATURE; CYSTIC FIBROSIS; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HUMAN; LUNG FUNCTION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MOLECULAR TYPING; NUTRITION; TREATMENT OUTCOME;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BODY MASS INDEX; CHILD; CHRONIC DISEASE; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; HUMANS; LINEAR MODELS; LONGITUDINAL STUDIES; MALE; METHICILLIN; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; SEVERITY OF ILLNESS INDEX; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955974105     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.02.004     Document Type: Article

References (31)

1. Saiman L. Microbiology of early CF lung disease. Paediatr Respir Rev 2004, 5:S367-S369.
2. Razvi S., Quittell L., Sewall A., Quinton H., Marshall B., Saiman L. Respiratory microbiology of patients with cystic fibrosis in the United States, 1995-2005. Chest 2009, 8:8.
3. Klevens R.M., Edwards J.R., Tenover F.C., McDonald L.C., Horan T., Gaynes R. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006, 42:389-391.
4. Miall L.S., McGinley N.T., Brownlee K.G., Conway S.P. Methicillin resistant Staphylococcus aureus (MRSA) infection in cystic fibrosis. Arch Dis Child 2001, 84:160-162.
5. Thomas S.R., Gyi K.M., Gaya H., Hodson M.E. Methicillin-resistant Staphylococcus aureus: impact at a national cystic fibrosis centre. J Hosp Infect 1998, 40:203-209.
6. Ren C.L., Morgan W.J., Konstan M.W., et al. Presence of methicillin resistant Staphylococcus aureus in respiratory cultures from cystic fibrosis patients is associated with lower lung function. Pediatr Pulmonol 2007, 42:513-518.
7. Sawicki G.S., Rasouliyan L., Pasta D.J., et al. The impact of incident methicillin resistant Staphylococcus aureus detection on pulmonary function in cystic fibrosis. Pediatr Pulmonol 2008, 43:1117-1123.
8. Dasenbrook E.C., Merlo C.A., Diener-West M., Lechtzin N., Boyle M.P. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008, 178:814-821.
9. Dasenbrook E.C., Checkley W., Merlo C.A., Konstan M.W., Lechtzin N., Boyle M.P. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA 2010, 303:2386-2392.
10. Goodrich J.S., Sutton-Shields T.N., Kerr A., Wedd J.P., Miller M.B., Gilligan P.H. Prevalence of community-associated methicillin-resistant Staphylococcus aureus in patients with cystic fibrosis. J Clin Microbiol 2009, 47:1231-1233.
11. Rosenstein B.J. What is a cystic fibrosis diagnosis?. Clin Chest Med 1998, 19:423-441.
12. Lee T.W., Brownlee K.G., Conway S.P., Denton M., Littlewood J.M. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003, 2:29-34.
13. Kosorok M.R., Zeng L., West S.E., et al. Acceleration of lung disease in children with cystic fibrosis after Pseudomonas aeruginosa acquisition. Pediatr Pulmonol 2001, 32:277-287.
14. Hankinson J.L., Odencrantz J.R., Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
15. Quanjer P.H., Borsboom G.J., Brunekreef B., et al. Spirometric reference values for white European children and adolescents: Polgar revisited. Pediatr Pulmonol 1995, 19:135-142.
16. Eigen H., Bieler H., Grant D., et al. Spirometric pulmonary function in healthy preschool children. Am J Respir Crit Care Med 2001, 163:619-623.
17. Wang X., Dockery D.W., Wypij D., Fay M.E., Ferris B.G. Pulmonary function between 6 and 18years of age. Pediatr Pulmonol 1993, 15:75-88.
18. Miller M., Gilligan P.H. Laboratory aspects of management of chronic pulmonary infections in patients with cystic fibrosis. J Clin Microbiol 2003, 41:4009-4015.
19. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing 2009, CLSI. 19th ed.
20. Diggle PJ L.K.-Y., Zeger S.L. Analysis of longitudinal data 1994, Clarendon Press, Oxford.
21. D'Agata E.M., Webb G.F., Horn M.A., Moellering R.C., Ruan S. Modeling the invasion of community-acquired methicillin-resistant Staphylococcus aureus into hospitals. Clin Infect Dis 2009, 48:274-284.
22. Saiman L., Cronquist A., Wu F., et al. An outbreak of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit. Infect Control Hosp Epidemiol 2003, 24:317-321.
23. David M., Glikman D., Crawford S.E., et al. What is community associated methicillin resistant Staphylococcus aureus?. J Infect Dis 2008, 197:1235-1243.
24. Carleton H.A., Diep B.A., Charlebois E.D., Sensabaugh G.F., Perdreau-Remington F. Community-adapted methicillin-resistant Staphylococcus aureus (MRSA): population dynamics of an expanding community reservoir of MRSA. J Infect Dis 2004, 190:1730-1738.
25. Zhang K., McClure J.A., Elsayed S., Tan J., Conly J.M. Coexistence of Panton-Valentine leukocidin-positive and -negative community-associated methicillin-resistant Staphylococcus aureus USA400 sibling strains in a large Canadian health-care region. J Infect Dis 2008, 197:195-204.
26. Rossney A.S., Shore A.C., Morgan P.M., Fitzgibbon M.M., O'Connell B., Coleman D.C. The emergence and importation of diverse genotypes of methicillin-resistant Staphylococcus aureus (MRSA) harboring the Panton-Valentine leukocidin gene (pvl) reveal that pvl is a poor marker for community-acquired MRSA strains in Ireland. J Clin Microbiol 2007, 45:2554-2563.
27. Stone A., Quittell L., Zhou J., Alba L., Bhat M., DeCelie-Germana J., et al. Epidemiology of anterior nares colonization with Staphylococcus aureus in children with CF and their household members. Ped Pulmonol 2007, 42:317.
28. Glikman D., Siegel J.D., David M.Z., et al. Complex molecular epidemiology of methicillin-resistant Staphylococcus aureus isolates from children with cystic fibrosis in the era of epidemic community-associated methicillin-resistant S aureus. Chest 2008, 133:1381-1387.
29. Mishaan A.M., Mason E.O., Martinez-Aguilar G., et al. Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 2005, 24:201-206.
30. Elizur A., Orscheln R.C., Ferkol T.W., et al. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus lung infection in patients with cystic fibrosis. Chest 2007, 131:1718-1725.
31. Taccetti G., Neri A.S., Festini F., Galici V., Cocchi P., Campana S. Methicillin resistant Staphylococcus aureus in cystic fibrosis. Ped Pulmonol 2008, 43:309.